| 000 | 04659nam a22004575i 4500 | ||
|---|---|---|---|
| 001 | 978-1-4419-0020-3 | ||
| 003 | DE-He213 | ||
| 005 | 20140220084501.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 100907s2010 xxu| s |||| 0|eng d | ||
| 020 |
_a9781441900203 _9978-1-4419-0020-3 |
||
| 024 | 7 |
_a10.1007/978-1-4419-0020-3 _2doi |
|
| 050 | 4 | _aRC254-282 | |
| 072 | 7 |
_aMJCL _2bicssc |
|
| 072 | 7 |
_aMED062000 _2bisacsh |
|
| 082 | 0 | 4 |
_a616.994 _223 |
| 100 | 1 |
_aAlaoui-Jamali, Moulay. _eeditor. |
|
| 245 | 1 | 0 |
_aAlternative and Complementary Therapies for Cancer _h[electronic resource] : _bIntegrative Approaches and Discovery of Conventional Drugs / _cedited by Moulay Alaoui-Jamali. |
| 264 | 1 |
_aBoston, MA : _bSpringer US : _bImprint: Springer, _c2010. |
|
| 300 |
_aXX, 722p. 32 illus. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 505 | 0 | _aOverview of Efficacy and Limitation of Standard and Targeted Therapy for Malignant Disease Using Lung Cancer as a Case Study -- Integrative Complementary and Alternative Medicine for Cancer Care -- Overview of Current TCM Practice and Potential Impacts on Conventional Therapies -- Complementary and Alternative Medicine for Cancer Care in India: Basic and Clinical Perspectives -- Complementary and Alternative Medicine for Cancer Care in India: Basic and Clinical Perspective -- Integrated TCM for Cancer Care in China: Principles, Recipes, and Case Studies for Selected Sites -- Esophageal Cancer -- Gastric Cancer -- Colorectal Cancer -- Liver Cancer -- Pancreatic Cancer -- Breast Cancer -- Ovarian Cancer -- Prostate Cancer -- Kidney Cancer -- Bladder Cancer -- Brain Cancer -- Management of Complementary and Alternative Treatments for Cancer -- Complementary and Alternative Treatments for the Management of Cancer-Related Fatigue -- Complementary and Alternative Treatments for the Management of Cancer-Related Pain -- Clinical, Pharmacological, and Safety Issues Using Complementary Therapies -- Challenges Conducting Clinical Trials with Herbal Products in Oncology -- Herbal Product–Drug Interactions from a Pharmacological Perspective -- Patient–Physician Relationship -- Patient–Physician Relationship: Creating an Optimal Healing Environment -- Regulatory Issues -- Legal Issues in Alternative Treatment of Cancer -- Intellectual Property for Alternative Medicine -- From Practice to Basics -- Chemical-Biology of Natural Products from Medicinal Plants for Cancer Therapy -- Flavonoids in Cancer Prevention and Therapy: Chemistry, Pharmacology, Mechanisms of Action, and Perspectives for Cancer Drug Discovery -- Marine Natural Products and their Synthetic Derivatives for Cancer Therapy -- Natural Product-like Scaffolds for Molecular Dissection of Macromolecular Interactions and New Therapeutic Applications -- Mining Natural Product-Derived Molecules Against Cancer Targets: The Case of the Androgen Receptor in Prostate Cancer. | |
| 520 | _aManagement of advanced cancers by modern therapies can be hampered by the unavailability of efficient drugs, which explains in part the high mortality rates seen in patients with advanced cancers. Alternative therapies, particularly those using formulations derived from herbal, marine and animal products, are rich sources of chemically diverse and complex molecules with the potential to discover novel drugs. Alternative and Complementary Therapies for Cancer is unique in the field, as it presents the progress and limitations of alternative therapies through an unusual interface of traditional and modern concepts assembled by recognized experts (from China, India, USA, Canada, and Europe) in medical oncology, alternative medicine, cancer pharmacology and medicinal chemistry. Current developments from clinical and regulatory perspectives are presented, areas of controversy and potential integration of alternative and complementary therapies are highlighted, and future perspectives for the discovery of herbal constituents that may complement anticancer drugs are discussed. | ||
| 650 | 0 | _aMedicine. | |
| 650 | 0 | _aToxicology. | |
| 650 | 0 | _aAlternative medicine. | |
| 650 | 0 | _aOncology. | |
| 650 | 1 | 4 | _aMedicine & Public Health. |
| 650 | 2 | 4 | _aOncology. |
| 650 | 2 | 4 | _aComplementary & Alternative Medicine. |
| 650 | 2 | 4 | _aPharmacology/Toxicology. |
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9781441900197 |
| 856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-1-4419-0020-3 |
| 912 | _aZDB-2-SME | ||
| 999 |
_c110170 _d110170 |
||